Form 10-K CorMedix Inc. For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Needham Starts NeoVolta (NEOV) at Buy
- Rockstar Games opens GTA VI pre-orders, priced at $79.99
- Rubio meets Gulf leaders, pledges security amid Iran deal doubts
- Hertz cuts guidance, announces notes and stock offerings, shares sink
CorMedix (CRMD) PT Lowered to $9 at RBC Capital
March 13, 2024 6:21 AM EDTRBC Capital analyst Gregory Renza lowered the price target on CorMedix (NASDAQ: CRMD) to $9.00 (from $10.00) while maintaining a Outperform rating.
The analyst comments "CRMD reported 4Q, with consistent messaging and incremental updates on launch & reimbursement strategy, into the reaffirmed proposed 4/15 inpatient launch, and... More
